SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-21-037525
Filing Date
2021-07-19
Accepted
2021-07-19 16:53:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea144454-8k_cmlife.htm DEFA14A 30762
  Complete submission text file 0001213900-21-037525.txt   31774
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10020
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10020 212 474 6700
CM Life Sciences, Inc. (Filer) CIK: 0001818331 (see all company filings)

IRS No.: 851966622 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39482 | Film No.: 211098421
SIC: 8000 Services-Health Services